Dual effects of rabeprazole on solid-phase gastric emptying assessed by the 13C-octanoate breath test

Digestion. 2005;72(2-3):189-94. doi: 10.1159/000088465. Epub 2005 Sep 21.

Abstract

Background/aims: Knowledge is limited regarding the effects of rabeprazole on gastric emptying. This randomized, open, crossover study was undertaken to investigate the effects.

Methods: In 24 healthy volunteers (13 men and 11 women, aged 22-53 years), solid emptying was assessed twice using the 13C-octanoate breath test. On one occasion, the subjects received 20 mg rabeprazole for the preceding 2 days and 1 h before the test. On another occasion, they underwent no pretreatment. The time course of cumulative recovery of 13CO2 in breath was fitted to z(t)=m(1-e-kt)beta-1, and regression constants of k and beta were determined. The half 13CO2 excretion time (t(1/2)b)) and the time of maximal excretion (tmax) were calculated. Under the crossover protocol, k and beta can describe the emptying features more precisely; a larger (smaller) beta indicates a slower (faster) emptying in the early phase, and a larger (smaller) k indicates a faster (slower) emptying in the later phase. Between the two occasions, k, beta, t(1/2)b, and tmax were compared.

Results: Rabeprazole significantly decreased k and beta, significantly prolonged t(1/2)b, but tmax remained unchanged.

Conclusion: Rabeprazole has dual effects on solid emptying: an initial acceleration with a subsequent deceleration, resulting in an overall delay.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Adult
  • Anti-Ulcer Agents / pharmacology*
  • Benzimidazoles / pharmacology*
  • Breath Tests / methods
  • Caprylates
  • Carbon Isotopes
  • Cross-Over Studies
  • Female
  • Gastric Emptying / drug effects*
  • Humans
  • Male
  • Middle Aged
  • Omeprazole / analogs & derivatives*
  • Omeprazole / pharmacology
  • Rabeprazole
  • Regression Analysis

Substances

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Anti-Ulcer Agents
  • Benzimidazoles
  • Caprylates
  • Carbon Isotopes
  • Rabeprazole
  • Omeprazole